Helius Medical Technologies (NASDAQ:HSDT) Announces Quarterly Earnings Results, Misses Estimates By $0.09 EPS

Helius Medical Technologies (NASDAQ:HSDT) posted its quarterly earnings results on Tuesday. The company reported ($1.03) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.94) by ($0.09), Zacks reports. Helius Medical Technologies had a negative net margin of 1,764.74% and a negative return on equity of 244.82%.

Helius Medical Technologies Stock Performance

HSDT traded up $0.02 during trading on Tuesday, reaching $0.41. 15,829 shares of the stock were exchanged, compared to its average volume of 2,801,606. The stock’s 50 day moving average price is $0.57 and its two-hundred day moving average price is $0.60. Helius Medical Technologies has a twelve month low of $0.37 and a twelve month high of $7.19. The stock has a market cap of $1.53 million, a P/E ratio of -0.07 and a beta of 1.62.

About Helius Medical Technologies

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.